Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.

Chao C, Zhang ZF, Berthiller J, Boffetta P, Hashibe M.

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):979-87.

2.
3.

Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: a meta-analysis.

Chen J, Lin Y, Zhang R, Huang ZJ, Pan XG.

Arch Med Res. 2012 Jan;43(1):58-66. doi: 10.1016/j.arcmed.2012.01.005. Epub 2012 Feb 2.

PMID:
22306249
4.

An association between NQO1 genetic polymorphism and risk of bladder cancer.

Park SJ, Zhao H, Spitz MR, Grossman HB, Wu X.

Mutat Res. 2003 Apr 20;536(1-2):131-7.

PMID:
12694753
5.

Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.

Pandith AA, Khan NP, Shah ZA, Shah AM, Wani SM, Siddiqi MA.

Biochem Genet. 2011 Aug;49(7-8):417-26. doi: 10.1007/s10528-011-9418-8. Epub 2011 Jan 21.

PMID:
21253823
6.

An association between a NQO1 genetic polymorphism and risk of lung cancer.

Saldivar SJ, Wang Y, Zhao H, Shao L, Lin J, Spitz MR, Wu X.

Mutat Res. 2005 Apr 4;582(1-2):71-8.

PMID:
15781212
7.

The association between NQO1 Pro187Ser polymorphism and bladder cancer susceptibility: a meta-analysis of 15 studies.

Yang S, Jin T, Su HX, Zhu JH, Wang DW, Zhu SJ, Li S, He J, Chen YH.

PLoS One. 2015 Jan 20;10(1):e0116500. doi: 10.1371/journal.pone.0116500. eCollection 2015.

8.

The NQO1 C609T polymorphism and risk of lung cancer: a meta-analysis.

Liu Y, Zhang D.

Asian Pac J Cancer Prev. 2011;12(11):3091-5.

9.

NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese.

Hamajima N, Matsuo K, Iwata H, Shinoda M, Yamamura Y, Kato T, Hatooka S, Mitsudomi T, Suyama M, Kagami Y, Ogura M, Ando M, Sugimura Y, Tajima K.

Int J Clin Oncol. 2002 Apr;7(2):103-8.

PMID:
12018106
10.

The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis.

Peng Q, Lu Y, Lao X, Chen Z, Li R, Sui J, Qin X, Li S.

Diagn Pathol. 2014 May 29;9:100. doi: 10.1186/1746-1596-9-100. Review.

11.

NAD(P)H: quinone oxidoreductase polymorphism and lung cancer in Taiwan.

Lin P, Wang HJ, Lee H, Lee HS, Wang SL, Hsueh YM, Tsai KJ, Chen CY.

J Toxicol Environ Health A. 1999 Oct 29;58(4):187-97.

PMID:
10591487
12.

The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior.

Xu LL, Wain JC, Miller DP, Thurston SW, Su L, Lynch TJ, Christiani DC.

Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):303-9.

13.

Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population.

Lewis SJ, Cherry NM, Niven RM, Barber PV, Povey AC.

Lung Cancer. 2001 Nov;34(2):177-83.

PMID:
11679176
14.

Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.

Gong M, Yi Q, Wang W.

Tumour Biol. 2013 Oct;34(5):2551-6. doi: 10.1007/s13277-013-0799-7. Epub 2013 Jun 8. Review.

PMID:
23749485
15.

Association of polymorphisms in iNOS and NQO1 with bladder cancer risk in cigarette smokers.

Huang ZM, Chen HA, Chiang YT, Shen CH, Tung MC, Juang GD.

J Chin Med Assoc. 2014 Feb;77(2):83-8. doi: 10.1016/j.jcma.2013.10.005. Epub 2013 Dec 5.

16.

NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors.

Lafuente MJ, Casterad X, Trias M, Ascaso C, Molina R, Ballesta A, Zheng S, Wiencke JK, Lafuente A.

Carcinogenesis. 2000 Oct;21(10):1813-9.

PMID:
11023538
17.

Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China.

Yin L, Pu Y, Liu TY, Tung YH, Chen KW, Lin P.

Lung Cancer. 2001 Aug-Sep;33(2-3):133-41.

PMID:
11551408
18.

NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study.

Bock CH, Wenzlaff AS, Cote ML, Land SJ, Schwartz AG.

Carcinogenesis. 2005 Feb;26(2):381-6. Epub 2004 Oct 21.

PMID:
15498787
19.

Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis.

Liu K, Tian H, Yu KZ, Shen WY, Mao ZC, Jin CH, Pan HB, He JX.

Tumour Biol. 2014 Mar;35(3):2063-8. doi: 10.1007/s13277-013-1273-2. Epub 2013 Nov 10.

PMID:
24213850
20.

NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a meta-analysis based on 21 case-control studies.

Yang FY, Guan QK, Cui YH, Zhao ZQ, Rao W, Xi Z.

Eur J Cancer Prev. 2012 Sep;21(5):432-41. doi: 10.1097/CEJ.0b013e32834f7514. Review.

PMID:
22387672

Supplemental Content

Support Center